Disparities in cancer care-A call to action

Inas Abuali; Shruti Patel; Lauren Kiel; Kelly Meza; Narjust Florez

doi:10.1016/j.ccell.2022.11.003

Disparities in cancer care-A call to action

Cancer Cell. 2023 Jan 9;41(1):1-4. doi: 10.1016/j.ccell.2022.11.003. Epub 2022 Dec 8.

Authors

Inas Abuali¹, Shruti Patel², Lauren Kiel³, Kelly Meza³, Narjust Florez⁴

Affiliations

¹ Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
² Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA.
³ Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Division of Hematology/Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
⁴ Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Division of Hematology/Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: narjust_florez@dfci.harvard.edu.

PMID: 36626866
DOI: 10.1016/j.ccell.2022.11.003

Abstract

Disparities in cancer care disproportionately impact minority groups, members of which face challenges in accessing high-quality cancer care, remain underrepresented in clinical trials, and experience significant financial toxicity and discrimination during their cancer journey. Diversifying our workforce, improving access to trials, and allocating research funding for equitable initiatives should be prioritized.

MeSH terms

Humans
Minority Groups*
Neoplasms* / therapy